← Back to all trials
Completed
NCT05749536
Pharmacokinetics of Procaterol in Elite Athletes
Conditions: Asthma
Sex: Male
Ages: 18 Years – 45 Years
Healthy volunteers: 1
Enrollment: 20
Sponsor: Bispebjerg Hospital
Location: Denmark
Summary
The purpose of the study is to find blood and urine concentrations of procaterol administrated either by inhalation or by tablets in asthmatic and non-asthmatics males.
We hypotheis that the concentrations of procaterol in the blood and serum is higher after tablet intake versus inhalation.
Eligibility Criteria
Inclusion Criteria:Doctor diagnosed asthma for the asthmatic groupGINA 1-3 for the asthmatic groupUse of beta2-agonist for at least 12 months for the asthmatic groupage 18-45malesinformed consentExclusion Criteria:smoker or former smokerairway infection to weeks prior to the study or during the studyother chronic diseaes than asthma and allergyUse of beta2-agonist 6 days prior to the studyAllergy to the study medicine
Source: ClinicalTrials.gov (NCT05749536). StuddyBuddy aggregates publicly available trial information.
